hydralazine has been researched along with amiloride in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Newell, K; Stratford, I; Tannock, I; Wood, P | 1 |
| Diakos, A; Kontoyannis, DA; Kontoyannis, SA; Moulopoulos, SD; Sideris, DA | 1 |
| Löllgen, H; Schmidt, A; Upmeyer, HJ | 1 |
| Hasuda, K; Lee, C; Tannock, IF | 1 |
| Luo, J; Tannock, IF | 1 |
| Tannock, IF; Yamagata, M | 1 |
| Iwai, N; Nishimura, M; Ohtsuka, K; Takahashi, H; Yoshimura, M | 1 |
1 review(s) available for hydralazine and amiloride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for hydralazine and amiloride
| Article | Year |
|---|---|
[Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Amiloride; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation | 1986 |
10 other study(ies) available for hydralazine and amiloride
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.
Topics: Amiloride; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Division; Cell Survival; Fibrosarcoma; Homeostasis; Hydralazine; Hydrogen-Ion Concentration; Kinetics; Mice; Nigericin; Sarcoma, Experimental; Tumor Cells, Cultured | 1992 |
Antihypertensive treatment for the management of premature ventricular complexes. Pilot study.
Topics: Adult; Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Blood Pressure; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Infusions, Intravenous; Male; Metaraminol; Methyldopa; Middle Aged; Nitroprusside | 1988 |
Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH.
Topics: Amiloride; Animals; Cell Hypoxia; Cell Survival; Combined Modality Therapy; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fibrosarcoma; Glucose; Hydralazine; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Nigericin; Organoids; Protons; Sarcoma, Experimental | 1994 |
Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.
Topics: Amiloride; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Death; Combined Modality Therapy; Disease Models, Animal; Flow Cytometry; Hydralazine; Hydrogen-Ion Concentration; Intracellular Fluid; Kinetics; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nigericin; Sarcoma, Experimental; Sodium-Hydrogen Exchangers; Tumor Cells, Cultured | 1994 |
The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Antineoplastic Agents; Antiporters; Bicarbonates; Cell Line; Cell Survival; Chloride-Bicarbonate Antiporters; Chlorides; Female; Fibrosarcoma; Hydralazine; Hydrogen-Ion Concentration; Kinetics; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nigericin; Sarcoma, Experimental; Sodium-Hydrogen Exchangers; Tumor Cells, Cultured | 1996 |
Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels.
Topics: Amiloride; Animals; Arginine Vasopressin; Blood Pressure; Brain; Brain Chemistry; Desoxycorticosterone; DNA Primers; Gene Expression Regulation, Enzymologic; Heart Rate; Hydralazine; Hypertension, Renal; Injections, Intraventricular; Male; Norepinephrine; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium Channels; Sodium Chloride; Vasodilator Agents | 1999 |